Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
April 28 2021 - 4:05PM
Esperion (NASDAQ: ESPR) today announced that, on April 23, 2021,
the Compensation Committee of Esperion’s Board of Directors granted
21 new employees 50,991 restricted stock units (RSUs) under
Esperion’s 2017 Inducement Equity Incentive Plan.
The 2017 Inducement Equity Incentive Plan is
used exclusively for the grant of equity awards to individuals who
were not previously an employee or non-employee director of
Esperion (or following a bona fide period of non-employment), as an
inducement material to such individual's entering into employment
with Esperion, pursuant to Rule 5635(c)(4) of the NASDAQ Listing
Rules.
Each RSU will vest as to twenty-five percent of
the shares on the one-year anniversary of the recipient’s vesting
commencement date, and will vest and become exercisable as to the
remaining 75 percent of the shares in twelve equal quarterly
installments at the end of each quarter following such anniversary,
in each case, subject to each such employee's continued employment
with Esperion on such vesting dates. The RSUs are subject to the
terms and conditions of Esperion’s 2017 Inducement Equity Incentive
Plan, and the terms and conditions of the RSU agreement covering
the grant.
Esperion Therapeutics
ESPERION is The Lipid Management Company. Our
goal is lipid management for everybody, that’s why we work hard to
make our medicines easy to get, easy to take and easy to have. We
discover, develop and commercialize innovative medicines and
combinations to lower cholesterol, especially for patients whose
needs aren’t being met by the status quo. Our entrepreneurial team
of industry leaders is inclusive, passionate and resourceful. We
are singularly focused on managing cholesterol so you can improve
your health easily. For more information, please visit
www.esperion.com and follow us on Twitter at
www.twitter.com/EsperionInc.
Contact:Kaitlyn
BroscoEsperioncorporateteam@esperion.com
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jul 2023 to Jul 2024